Dawei Shi

1.4k total citations
48 papers, 811 citations indexed

About

Dawei Shi is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Dawei Shi has authored 48 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Dawei Shi's work include Pneumonia and Respiratory Infections (10 papers), Microbial infections and disease research (9 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Dawei Shi is often cited by papers focused on Pneumonia and Respiratory Infections (10 papers), Microbial infections and disease research (9 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Dawei Shi collaborates with scholars based in China, United States and India. Dawei Shi's co-authors include Deli Xin, Ziye Zhou, Ying Dai, Jing Li, Sihong Xu, Shaojie Ma, Xu Han, Min Yue, Guanyang Lin and Xuben Yu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Dawei Shi

46 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawei Shi China 17 273 237 231 145 73 48 811
Shisong Fang China 14 244 0.9× 229 1.0× 352 1.5× 64 0.4× 60 0.8× 65 866
Jane M. Knisely United States 9 129 0.5× 342 1.4× 128 0.6× 51 0.4× 40 0.5× 12 920
Ayşegül Yağcı Türkiye 15 243 0.9× 545 2.3× 391 1.7× 89 0.6× 33 0.5× 46 1.1k
Soichiro Kimura Japan 18 173 0.6× 312 1.3× 200 0.9× 53 0.4× 21 0.3× 46 808
Irene Ang Hong Kong 15 307 1.1× 262 1.1× 60 0.3× 87 0.6× 39 0.5× 20 855
Xiangke Duan China 14 156 0.6× 297 1.3× 212 0.9× 61 0.4× 20 0.3× 31 591
Judit Szabó Hungary 18 182 0.7× 456 1.9× 177 0.8× 52 0.4× 29 0.4× 65 1.1k
Carine Rouanet France 14 336 1.2× 231 1.0× 317 1.4× 144 1.0× 15 0.2× 20 847
Riana Cockeran South Africa 17 494 1.8× 188 0.8× 145 0.6× 132 0.9× 19 0.3× 40 922
Sultan Ahmed Bangladesh 17 107 0.4× 218 0.9× 159 0.7× 119 0.8× 29 0.4× 48 800

Countries citing papers authored by Dawei Shi

Since Specialization
Citations

This map shows the geographic impact of Dawei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Shi more than expected).

Fields of papers citing papers by Dawei Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Shi. The network helps show where Dawei Shi may publish in the future.

Co-authorship network of co-authors of Dawei Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Dawei Shi. A scholar is included among the top collaborators of Dawei Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawei Shi. Dawei Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shirong, Dawei Shi, Ruixia Yuan, et al.. (2025). P1 adhesin genotype characteristics of Mycoplasma pneumoniae in China from 2017 to 2019. Frontiers in Cellular and Infection Microbiology. 15. 1513177–1513177. 1 indexed citations
2.
3.
Xue, Chunyuan, Yimeng Du, Jigui Shan, et al.. (2025). TIMM10 enhances MAVS mediated innate immune response against influenza A virus infection. Colloids and Surfaces A Physicochemical and Engineering Aspects. 718. 136900–136900.
4.
Zhang, Zhikun, et al.. (2024). Mycoplasma pneumoniae regulates the expression of GP130 in lung epithelial cells through apoptosis and TLR4/ NF-κB pathway during infection. Microbial Pathogenesis. 197. 107072–107072. 1 indexed citations
5.
Zhang, Chunhong, Furong Li, Ying Dai, et al.. (2024). Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study. Frontiers in Pharmacology. 15. 1309540–1309540. 2 indexed citations
6.
Tian, Xiangdong, et al.. (2023). Rapid classification of SARS-CoV-2 variant strains using machine learning-based label-free SERS strategy. Talanta. 267. 125080–125080. 17 indexed citations
7.
Wang, Yuzhen, Chuang Chen, Ying Dai, et al.. (2023). Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection. British Journal of Clinical Pharmacology. 90(2). 452–462. 2 indexed citations
8.
Shi, Dawei, et al.. (2022). Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System. British Journal of Clinical Pharmacology. 89(4). 1386–1392. 5 indexed citations
9.
Zhang, Zhikun, Peng Tu, Dawei Shi, et al.. (2022). Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae pneumonia. Frontiers in Immunology. 13. 1088725–1088725. 24 indexed citations
10.
Wu, Fan, Xiaoshan Zhang, Ying Dai, et al.. (2022). Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients. Frontiers in Pharmacology. 13. 844567–844567. 16 indexed citations
11.
Feng, Rui, Lei Wang, Dawei Shi, et al.. (2021). Structural basis for neutralization of an anicteric hepatitis associated echovirus by a potent neutralizing antibody. Cell Discovery. 7(1). 35–35. 3 indexed citations
12.
Wang, Chongwen, Dawei Shi, Nan Chi Wan, et al.. (2021). Development of spike protein-based fluorescence lateral flow assay for the simultaneous detection of SARS-CoV-2 specific IgM and IgG. The Analyst. 146(12). 3908–3917. 48 indexed citations
13.
14.
Ye, Ke, Dawei Shi, Zhigao Zhang, et al.. (2021). A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine. Vaccine. 39(51). 7470–7476. 10 indexed citations
15.
Dai, Ying, Guanyang Lin, & Dawei Shi. (2020). Hypoglycemia Induced by Hydroxychloroquine Sulfate in a Patient Treated for Connective Tissue Disease Without Diabetes Mellitus. Clinical Therapeutics. 42(5). 940–945. 9 indexed citations
16.
Dai, Ying, Yingying Wang, Yifan Zeng, et al.. (2020). Linezolid and the risk of lactic acidosis: Data mining and analysis of the FDA Adverse Event Reporting System. Journal of Clinical Pharmacy and Therapeutics. 45(6). 1422–1426. 16 indexed citations
17.
Shi, Dawei, et al.. (2020). The inhibitory effects of shikonin and β,β-dimethylacrylshikonin on tramadol metabolism in vitro and in vivo. Journal of Pharmacy and Pharmacology. 72(9). 1232–1238. 2 indexed citations
18.
Shi, Dawei, et al.. (2019). Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis. Clinical Drug Investigation. 39(9). 847–856. 9 indexed citations
19.
Zhou, Ziye, et al.. (2019). Clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin. Journal of Clinical Pharmacy and Therapeutics. 45(1). 191–198. 7 indexed citations
20.
Chen, Yan, Bin Wu, Liangliang Xu, et al.. (2011). A SNX10/V-ATPase pathway regulates ciliogenesis in vitro and in vivo. Cell Research. 22(2). 333–345. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shisong Fang Breakdown of academic impact, for papers by Jane M. Knisely Breakdown of academic impact, for papers by Ayşegül Yağcı Breakdown of academic impact, for papers by Soichiro Kimura Breakdown of academic impact, for papers by Irene Ang Breakdown of academic impact, for papers by Xiangke Duan Breakdown of academic impact, for papers by Judit Szabó Breakdown of academic impact, for papers by Carine Rouanet Breakdown of academic impact, for papers by Riana Cockeran Breakdown of academic impact, for papers by Sultan Ahmed
Rankless by CCL
2026